Search
-
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
(PLoS Neglected Tropical Diseases. vol. 14, n° 6, pp. e0008259, 2020)Article de revueOpen access -
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
(EBioMedicine. vol. 74, 2021-11-09)Article de revueOpen access -
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
(The Lancet Infectious Diseases, 2020)Article de revue -
Dermatoses in international travellers seen at Bordeaux teaching hospital travel clinic, 2015-2018: a GeoSentinel-based study
(Clinical and Experimental Dermatology. vol. 45, n° 5, pp. 580-583, 2020)Article de revueOpen access -
Zika among international travellers presenting to GeoSentinel sites, 2012-2019: implications for clinical practice
(Journal of Travel Medicine. vol. 27, n° 4, 2020)Article de revue -
Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study
(Journal of Clinical Virology. vol. 141, pp. 104878, 2021-06-05)Article de revue -
France's COVID-19 response: balancing conflicting public health traditions
(Lancet. vol. 396, n° 10246, pp. 219-221, 2020)Article de revue -
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
(PLoS Neglected Tropical Diseases. vol. 18, n° 4, pp. e0011500, 2024-04-11)Article de revueOpen access -
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data
(The Lancet Regional Health - Europe. vol. 1, pp. 100001, 2021-02)Article de revueOpen access -
Monitoring of SARS-CoV-2 in wastewater: what normalisation for improved understanding of epidemic trends?
(Journal of Water and Health. vol. 20, n° 4, pp. 712-726, 2022-04-01)Article de revueOpen access